Hereditary angioedema: an update on causes, manifestations and treatment
HJ Longhurst, K Bork - British Journal of Hospital Medicine, 2019 - magonlinelibrary.com
… Hereditary angioedema therapy relies on treatment of acute attacks, and short- and long-term …
with C1-INH concentrate, icatibant or ecallantide; tranexamic acid or androgens are …
with C1-INH concentrate, icatibant or ecallantide; tranexamic acid or androgens are …
Hereditary angioedema: On-demand treatment of angioedema attacks.
SC Christiansen, BL Zuraw - Allergy & Asthma Proceedings, 2020 - search.ebscohost.com
… acute treatment for angioedema has been fundamental in reducing the burden of illness for
patients with hereditary angioedema (HAE… The plasma kallikrein inhibitor ecallantide and the …
patients with hereditary angioedema (HAE… The plasma kallikrein inhibitor ecallantide and the …
[HTML][HTML] Optimum use of acute treatments for hereditary angioedema: evidence-based expert consensus
H Longhurst - Frontiers in Medicine, 2018 - frontiersin.org
… Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema
attacks. J Allergy Clin Immunol Pract (2015) 3(2):206–12. doi:10.1016/j.jaip.2014.09.001 …
attacks. J Allergy Clin Immunol Pract (2015) 3(2):206–12. doi:10.1016/j.jaip.2014.09.001 …
Acute management of hereditary angioedema attacks
CH Katelaris - Immunology and Allergy Clinics, 2017 - immunology.theclinics.com
Modern management of hereditary angioedema (HAE) includes managing the acute attack, …
that place the patient at risk of an attack, and long-term management for those where the …
that place the patient at risk of an attack, and long-term management for those where the …
Clinical manifestations of hereditary angioedema and a systematic review of treatment options
M Rosi‐Schumacher, SJ Shah… - Laryngoscope …, 2021 - Wiley Online Library
… on the management of hereditary angioedema (HAE) and … , ecallantide (30 mg subcutaneous)
was tested specifically in patients with hereditary angioedema suffering laryngeal attacks …
was tested specifically in patients with hereditary angioedema suffering laryngeal attacks …
Management of hereditary angioedema in Japan: focus on icatibant for the treatment of acute attacks
M Hide, T Horiuchi, I Ohsawa, I Andresen… - Allergology …, 2021 - jstage.jst.go.jp
… , so patients are unable to treat acute attacks at home.Additionally, finding a medical facility
at … demonstrate efficacy of icatibant in treating acute attacks in patients with the PLG mutation.…
at … demonstrate efficacy of icatibant in treating acute attacks in patients with the PLG mutation.…
Current and emerging biologics for the treatment of hereditary angioedema
F Perego, MA Wu, A Valerieva, S Caccia… - Expert Opinion on …, 2019 - Taylor & Francis
… to treat severe life-threatening attacks … ecallantide in patients with hereditary angioedema
[Citation40,Citation41,Citation44]. The results for 30 mg subcutaneous injection of ecallantide …
[Citation40,Citation41,Citation44]. The results for 30 mg subcutaneous injection of ecallantide …
Icatibant as acute treatment for hereditary angioedema in adults
H Farkas - Expert Review of Clinical Pharmacology, 2016 - Taylor & Francis
… Ecallantide was approved as acute treatment in 2009, in the … severe as well as 30.2% of very
severe attacks were treated … shorter in self-treated than in HCP-treated attacks (1.5 vs. 2.4 h; …
severe attacks were treated … shorter in self-treated than in HCP-treated attacks (1.5 vs. 2.4 h; …
Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks
C Tyson, A Relan, P Adams, A Haynes… - Journal of Drug …, 2019 - Taylor & Francis
… 0.786 for ecallantide. At a mean annual attack rate of 26.9, cost per QALY was $402,769 for
rhC1-INH, $475,942 for icatibant, $462,275 for pdC1-INH, and $666,153 for ecallantide. Re-…
rhC1-INH, $475,942 for icatibant, $462,275 for pdC1-INH, and $666,153 for ecallantide. Re-…
[PDF][PDF] Current and emerging therapies to prevent hereditary angioedema attacks
WR Lumry - Am J Manag Care, 2018 - ajmc.s3.amazonaws.com
… -controlled trials of ecallantide for acute attacks of hereditary angioedema. Expert Rev Clin
… antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 …
… antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 …